Medicare Enrolled
Dr. Tarek Chidiac, MD
Medical Oncology · Columbus, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chidiac from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chidiac?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chidiac
Dr. Tarek Chidiac is a medical oncology specialist in Columbus, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chidiac performed 12,145 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chidiac received a total of $767,408 from 87 pharmaceutical and/or device companies across 1015 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chidiac is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 17% volume in OH
$767,408 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗12,145
Medicare services
Top 17% in OH for medical oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,205 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 3,770 | $1 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
848 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
449 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 360 | $1 | $41 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
255 | $91 | $390 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
117 | $8 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
111 | $93 | $421 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
104 | $60 | $277 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
98 | $5 | $126 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
95 | $21 | $103 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
55 | $77 | $210 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
52 | $5 | $16 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
51 | $39 | $381 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
51 | $136 | $550 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
50 | $153 | $754 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
48 | $1 | $4 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
43 | $10 | $67 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
43 | $11 | $66 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
35 | $44 | $208 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
31 | $44 | $205 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
29 | $24 | $121 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $100 | $406 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $108 | $509 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
26 | $40 | $269 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $61 | $214 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
25 | $771 | $4,447 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
25 | $43 | $180 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $122 | $595 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
19 | $26 | $86 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
18 | $75 | $334 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
14 | $5 | $17 |
| New patient office visit, complex (60-74 min) | 14 | $154 | $673 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.2% high complexity
87.4% medium
10.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$767,408
Total received (2018-2024)
Avg $109,630/year across 7 years
Top 1% in OH for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
1,015
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$58,912
2023
$153,436
2022
$144,163
2021
$153,757
2020
$104,112
2019
$116,148
2018
$36,880
Payments by company (2024)
Regeneron Healthcare Solutions, Inc.
$24,649
PFIZER INC.
$15,236
Karyopharm Therapeutics Inc.
$6,830
Takeda Pharmaceuticals U.S.A., Inc.
$5,081
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,740
Daiichi Sankyo Inc.
$1,524
AstraZeneca Pharmaceuticals LP
$1,044
ARRAY BIOPHARMA INC
$745
BeiGene USA, Inc.
$280
Novartis Pharmaceuticals Corporation
$225
JAZZ PHARMACEUTICALS INC.
$221
Merck Sharp & Dohme LLC
$120
Incyte Corporation
$105
ABBVIE INC.
$100
Eisai Inc.
$96
Astellas Pharma US Inc
$72
SOBI, INC
$66
Amneal Pharmaceuticals LLC
$58
Genentech USA, Inc.
$57
EMD Serono, Inc.
$56
Janssen Biotech, Inc.
$54
Kite Pharma, Inc.
$47
E.R. Squibb & Sons, L.L.C.
$45
GENZYME CORPORATION
$44
Blueprint Medicines Corporation
$39
Adaptive Biotechnologies Corporation
$38
Genmab U.S., Inc.
$36
Pharmacosmos Therapeutics Inc.
$35
Celgene Corporation
$31
Geron Corporation
$31
GlaxoSmithKline, LLC.
$26
SERVIER PHARMACEUTICALS LLC
$24
Alexion Pharmaceuticals, Inc.
$23
Lilly USA, LLC
$22
Aveo Pharmaceuticals, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$18
SpringWorks Therapeutics, Inc.
$18
Iovance Biotherapeutics, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$15
Gilead Sciences, Inc.
$14
ADC Therapeutics America, Inc.
$14
Top 3 companies account for 79.3% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$102,594
Rigel Pharmaceuticals, Inc.
$91,390
Incyte Corporation
$88,092
Karyopharm Therapeutics Inc.
$76,955
Dova Pharmaceuticals
$53,892
Amgen Inc.
$51,807
SOBI, INC
$47,464
Bayer HealthCare Pharmaceuticals Inc.
$40,608
Sobi, Inc
$35,213
PFIZER INC.
$26,970
AstraZeneca Pharmaceuticals LP
$25,867
Genentech USA, Inc.
$25,762
GENZYME CORPORATION
$15,041
ADC Therapeutics America, Inc.
$14,606
ARRAY BIOPHARMA INC
$8,245
Seattle Genetics, Inc.
$7,615
Gilead Sciences, Inc.
$6,276
Takeda Pharmaceuticals U.S.A., Inc.
$5,477
Novartis Pharmaceuticals Corporation
$4,875
Foundation Medicine, Inc.
$4,262
Pharmacosmos Therapeutics Inc.
$2,975
Taiho Oncology, Inc.
$2,947
E.R. Squibb & Sons, L.L.C.
$2,914
ARGENX US, INC.
$2,800
BeiGene USA, Inc.
$2,765
Celgene Corporation
$1,892
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,757
Daiichi Sankyo Inc.
$1,702
Aurobindo Pharma USA, Inc.
$1,671
Janssen Scientific Affairs, LLC
$1,641
JAZZ PHARMACEUTICALS INC.
$1,626
Janssen Biotech, Inc.
$1,219
AbbVie, Inc.
$1,181
Adaptive Biotechnologies Corporation
$1,084
Stemline Therapeutics Inc.
$970
Eagle Pharmaceuticals, Inc.
$850
Bayer Healthcare Pharmaceuticals Inc.
$656
Merck Sharp & Dohme LLC
$330
Eisai Inc.
$329
Pharmacyclics LLC, An AbbVie Company
$266
Lilly USA, LLC
$170
Pharmacyclics LLC, an AbbVie Company
$164
EMD Serono, Inc.
$148
Mirati Therapeutics, Inc.
$145
Astellas Pharma US Inc
$143
Sirtex Medical Inc
$142
Flowonix Medical Incorporated
$134
EISAI INC.
$117
ABBVIE INC.
$100
Agios Pharmaceuticals, Inc.
$100
Exelixis Inc.
$89
ASD SPECIALTY HEALTHCARE, LLC
$87
SERVIER PHARMACEUTICALS LLC
$79
Amneal Pharmaceuticals LLC
$76
Seagen Inc.
$76
CTI BioPharma Corp.
$75
GlaxoSmithKline, LLC.
$73
Ipsen Biopharmaceuticals, Inc
$68
Genmab U.S., Inc.
$66
Kite Pharma, Inc.
$62
Coherus Biosciences Inc.
$60
Dendreon Pharmaceuticals LLC
$58
MorphoSys, US Inc.
$50
Alexion Pharmaceuticals, Inc.
$47
Blueprint Medicines Corporation
$39
TAIHO ONCOLOGY, INC.
$37
G1 Therapeutics, Inc.
$35
Geron Corporation
$31
Jazz Pharmaceuticals Inc.
$28
Heron Therapeutics, Inc.
$22
Blue Earth Diagnostics Limited
$22
MENARINI SILICON BIOSYSTEMS, INC.
$22
AVEO Pharmaceuticals, Inc.
$21
SANOFI-AVENTIS U.S. LLC
$20
Aveo Pharmaceuticals, Inc.
$20
Kyowa Kirin, Inc.
$20
Pharming Healthcare, Inc.
$20
AMAG Pharmaceuticals, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$18
SpringWorks Therapeutics, Inc.
$18
Iovance Biotherapeutics, Inc.
$17
Acceleron Pharma, Inc.
$16
Merck Sharp & Dohme Corporation
$15
Secura Bio, Inc.
$15
Sumitomo Pharma America, Inc.
$14
MEDIVATION FIELD SOLUTIONS LLC
$13
Lexicon Pharmaceuticals, Inc.
$12
Top 3 companies account for 36.8% of all-time payments
Associated products mentioned in payments ›
ASPARLAS · AVASTIN · AYVAKIT · Abraxane · Aliqopa · Amtagvi · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · CABOMETYX · CALQUENCE · CD38 · COSELA · Cabometyx · Cellsearch · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONACT · FOUNDATIONONE · FOUNDATIONONE HEME · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · Gavreto · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INQOVI · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MONJUVI · MONOFERRIC · Monoferric · NINLARO · Nplate · OGSIVEO · OJJAARA · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PEMFEXY · PLUVICTO · POSLUMA · POTELIGEO · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · Prometra II · REBLOZYL · RETEVMO · ROZLYTREK · RUCONEST · RYBREVANT · RYTELO · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SYLVANT · SYNAGIS · Stivarga · TABRECTA · TAGRISSO · TECENTRIQ · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYVGART · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
70
County median income
$73,795
Nearest hospital to ZIP centroid (approximate)
RIVER VISTA HEALTH AND WELLNESS LLC
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chidiac is a mixed practice specialist, with above-average Medicare volume (top 17% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chidiac experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Chidiac performed 5,205 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chidiac receive payments from pharmaceutical companies?
Yes. Dr. Chidiac received a total of $767,408 from 87 companies across 1,015 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chidiac's costs compare to other medical oncologists in Columbus?
Dr. Chidiac's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chidiac) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Columbus
Browse medical oncologists in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in OH
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in OH
Which OH medical oncologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology